Statera Biopharma, Inc.
STABDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001318641
Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Statera Biopharma, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 23 | 29 | +6 |
| Shares | 1.22M | 2.03M | +813.1K (+66.7%) |
| Value | $2.81M | $4.64M | +$1.83M (+65.1%) |
New holders (10)
Institutions that held Statera Biopharma, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Potomac Capital Management, Inc. | 381,900 | $878.0K | 0.84% |
| Eaton Vance Management | 154,067 | $354.0K | 0.00% |
| Bell & Brown Wealth Advisors, LLC | 19,313 | $19.0K | 0.01% |
| Royal Bank of Canada | 5,000 | $12.0K | 0.00% |
| Simplex Trading, LLC | 3,912 | $8.00K | 0.00% |
| Financial Perspectives, Inc | 2,505 | $5.76K | 0.00% |
| National Bank of Canada | 500 | $1.00K | 0.00% |
| CWM, LLC | 450 | $1.00K | 0.00% |
| Accel Wealth Management | 250 | $1.00K | 0.00% |
| Umb Bank N A | 5 | $0 | 0.00% |
Sold out (4)
Institutions that held Statera Biopharma, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| UBS Group AG | 19,470 | $45.0K |
| Tower Research Capital LLC (TRC) | 13,891 | $32.0K |
| Susquehanna International Group, LLP | 12,619 | $29.0K |
| FMR LLC | 46 | $0 |